|
|
||||||||
The FASEB Journal, Vol 5, 3037-3046, Copyright © 1991 by The Federation of American Societies for Experimental Biology
REVIEWS |
KR Chien, KU Knowlton, H Zhu and S Chien
Department of Medicine, University of California, San Diego 92093.
Studies from both in vivo and in vitro model systems have provided an initial skeleton of the potential signaling pathways that might regulate cardiac genes during growth and hypertrophy. One of the first detectable changes in cardiac gene expression is the activation of a program of immediate early gene expression, which is distinct for the hypertrophic response, and is conserved in multiple models of both in vivo and in vitro hypertrophy. Diverse and distinct hormonal stimuli have been documented to activate several features of the hypertrophic response, including several autocrine and paracrine factors. Although the signaling mechanisms that link these factors with the activation of cardiac gene expression are unclear, recent studies suggest that the activation of protein kinase C may represent one of the most proximal common events in this signaling cascade. The activation of cardiac target genes induces a program of embryonic gene expression, including the atrial natriuretic factor (ANF) gene. The cis sequences that mediate cardiac-specific and inducible expression of an embryonic marker gene (ANF) can be segregated by studies in both cultured cell models and in vivo models of hypertrophy in transgenic mice, suggesting that specific sets of regulatory elements may exist for inducible expression of this class of cardiac gene responses. However, the induction of a constitutively expressed contractile protein gene (MLC- 2) is mediated by a set of conserved elements that regulate both cardiac-specific and inducible expression. Finally, a subset of cardiac muscle genes appears to be noninducible during in vivo or in vitro hypertrophy in myocardial cells, demonstrating specificity of transcriptional activation during the hypertrophic process. The development of a bona fide in vivo pressure overload model of hypertrophy in a small animal model that can be genetically manipulated, such as the in vivo murine model recently described, should allow a rigorous analysis of the role of these specific signaling mechanisms in the activation of the responses of cardiac genes during the hypertrophic process in vivo.
This article has been cited by other articles:
![]() |
C. P. Alibin, M. A. Kopilas, and H. D. I. Anderson Suppression of Cardiac Myocyte Hypertrophy by Conjugated Linoleic Acid: ROLE OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS {alpha} AND {gamma} J. Biol. Chem., April 18, 2008; 283(16): 10707 - 10715. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Takaya, T. Kawamura, T. Morimoto, K. Ono, T. Kita, A. Shimatsu, and K. Hasegawa Identification of p300-targeted Acetylated Residues in GATA4 during Hypertrophic Responses in Cardiac Myocytes J. Biol. Chem., April 11, 2008; 283(15): 9828 - 9835. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Horsthuis, A. C. Houweling, P. E.M.H. Habets, F. J. de Lange, H. el Azzouzi, D. E.W. Clout, A. F.M. Moorman, and V. M. Christoffels Distinct Regulation of Developmental and Heart Disease-Induced Atrial Natriuretic Factor Expression by Two Separate Distal Sequences Circ. Res., April 11, 2008; 102(7): 849 - 859. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Morris, B. Lei, Y.-X. Wu, G. A. Michelotti, and D. A. Schwinn The {alpha}1a-Adrenergic Receptor Occupies Membrane Rafts with Its G Protein Effectors but Internalizes via Clathrin-coated Pits J. Biol. Chem., February 1, 2008; 283(5): 2973 - 2985. [Abstract] [Full Text] [PDF] |
||||
![]() |
S J. Sangaralingham, M Y. Tse, and S. C Pang Estrogen protects against the development of salt-induced cardiac hypertrophy in heterozygous proANP gene-disrupted mice J. Endocrinol., July 1, 2007; 194(1): 143 - 152. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fernandez-Velasco, G. Ruiz-Hurtado, O. Hurtado, M. A. Moro, and C. Delgado TNF-{alpha} downregulates transient outward potassium current in rat ventricular myocytes through iNOS overexpression and oxidant species generation Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H238 - H245. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. W. Dorn II The Fuzzy Logic of Physiological Cardiac Hypertrophy Hypertension, May 1, 2007; 49(5): 962 - 970. [Full Text] [PDF] |
||||
![]() |
D. G. Gardner, S. Chen, D. J. Glenn, and C. L. Grigsby Molecular Biology of the Natriuretic Peptide System: Implications for Physiology and Hypertension Hypertension, March 1, 2007; 49(3): 419 - 426. [Full Text] [PDF] |
||||
![]() |
D. Xu, N. Li, Y. He, V. Timofeyev, L. Lu, H.-J. Tsai, I.-H. Kim, D. Tuteja, R. K. P. Mateo, A. Singapuri, et al. Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors PNAS, December 5, 2006; 103(49): 18733 - 18738. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Azakie, J. R. Fineman, and Y. He Myocardial transcription factors are modulated during pathologic cardiac hypertrophy in vivo J. Thorac. Cardiovasc. Surg., December 1, 2006; 132(6): 1262 - 1271. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Glauser and W. Schlegel Mechanisms of transcriptional regulation underlying temporal integration of signals Nucleic Acids Res., October 6, 2006; (2006) gkl654v3. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Hilfiker-Kleiner, A. Hilfiker, M. Castellazzi, K. C. Wollert, C. Trautwein, H. Schunkert, and H. Drexler JunD attenuates phenylephrine-mediated cardiomyocyte hypertrophy by negatively regulating AP-1 transcriptional activity Cardiovasc Res, July 1, 2006; 71(1): 108 - 117. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Montana and J. T. Littleton Expression Profiling of a Hypercontraction-induced Myopathy in Drosophila Suggests a Compensatory Cytoskeletal Remodeling Response J. Biol. Chem., March 24, 2006; 281(12): 8100 - 8109. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Morel, A. Marcantoni, M. Gastineau, R. Birkedal, F. Rochais, A. Garnier, A.-M. Lompre, G. Vandecasteele, and F. Lezoualc'h cAMP-Binding Protein Epac Induces Cardiomyocyte Hypertrophy Circ. Res., December 9, 2005; 97(12): 1296 - 1304. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Petersen, K. A. Krumholz, and B. A. Burleigh Toll-Like Receptor 2 Regulates Interleukin-1{beta}-Dependent Cardiomyocyte Hypertrophy Triggered by Trypanosoma cruzi Infect. Immun., October 1, 2005; 73(10): 6974 - 6980. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Wettschureck and S. Offermanns Mammalian G Proteins and Their Cell Type Specific Functions Physiol Rev, October 1, 2005; 85(4): 1159 - 1204. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Houweling, M. M. van Borren, A. F.M. Moorman, and V. M. Christoffels Expression and regulation of the atrial natriuretic factor encoding gene Nppa during development and disease Cardiovasc Res, September 1, 2005; 67(4): 583 - 593. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Gurantz, A. Yndestad, B. Halvorsen, O. V. Lunde, J. H. Omens, T. Ueland, P. Aukrust, C. D. Moore, J. Kjekshus, and B. H. Greenberg Etanercept or intravenous immunoglobulin attenuates expression of genes involved in post-myocardial infarction remodeling Cardiovasc Res, July 1, 2005; 67(1): 106 - 115. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-C. Battista, E. Calvo, A. Chorvatova, B. Comte, J. Corbeil, and M. Brochu Intra-uterine growth restriction and the programming of left ventricular remodelling in female rats J. Physiol., May 15, 2005; 565(1): 197 - 205. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Casey, P. G. Arthur, and M. A. Bogoyevitch Proteomic Analysis Reveals Different Protein Changes during Endothelin-1- or Leukemic Inhibitory Factor-induced Hypertrophy of Cardiomyocytes in Vitro Mol. Cell. Proteomics, May 1, 2005; 4(5): 651 - 661. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Klein, A. Schaefer, D. Hilfiker-Kleiner, D. Oppermann, P. Shukla, A. Quint, E. Podewski, A. Hilfiker, F. Schroder, M. Leitges, et al. Increased Collagen Deposition and Diastolic Dysfunction but Preserved Myocardial Hypertrophy After Pressure Overload in Mice Lacking PKC{epsilon} Circ. Res., April 15, 2005; 96(7): 748 - 755. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Poizat, P. L. Puri, Y. Bai, and L. Kedes Phosphorylation-Dependent Degradation of p300 by Doxorubicin-Activated p38 Mitogen-Activated Protein Kinase in Cardiac Cells Mol. Cell. Biol., April 1, 2005; 25(7): 2673 - 2687. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Xiang, J. Kong, S. Chen, L.-P. Cao, G. Qiao, W. Zheng, W. Liu, X. Li, D. G. Gardner, and Y. C. Li Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems Am J Physiol Endocrinol Metab, January 1, 2005; 288(1): E125 - E132. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Arya, V. Kedar, J. R. Hwang, H. McDonough, H.-H. Li, J. Taylor, and C. Patterson Muscle ring finger protein-1 inhibits PKC{epsilon} activation and prevents cardiomyocyte hypertrophy J. Cell Biol., December 20, 2004; 167(6): 1147 - 1159. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mathew, E. Mascareno, and M. A. Q. Siddiqui A Ternary Complex of Transcription Factors, Nished and NFATc4, and Co-activator p300 Bound to an Intronic Sequence, Intronic Regulatory Element, Is Pivotal for the Up-regulation of Myosin Light Chain-2v Gene in Cardiac Hypertrophy J. Biol. Chem., September 24, 2004; 279(39): 41018 - 41027. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Onan, L. Pipolo, E. Yang, R. D. Hannan, and W. G. Thomas Urotensin II Promotes Hypertrophy of Cardiac Myocytes via Mitogen-Activated Protein Kinases Mol. Endocrinol., September 1, 2004; 18(9): 2344 - 2354. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xia and M. Karmazyn Obligatory Role for Endogenous Endothelin in Mediating the Hypertrophic Effects of Phenylephrine and Angiotensin II in Neonatal Rat Ventricular Myocytes: Evidence for Two Distinct Mechanisms for Endothelin Regulation J. Pharmacol. Exp. Ther., July 1, 2004; 310(1): 43 - 51. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Tenhunen, B. Sarman, R. Kerkela, I. Szokodi, L. Papp, M. Toth, and H. Ruskoaho Mitogen-activated Protein Kinases p38 and ERK 1/2 Mediate the Wall Stress-induced Activation of GATA-4 Binding in Adult Heart J. Biol. Chem., June 4, 2004; 279(23): 24852 - 24860. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. W. DORN II and H. S. HAHN Genetic Factors in Cardiac Hypertrophy Ann. N.Y. Acad. Sci., May 1, 2004; 1015(1): 225 - 237. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. L. Davies, J. I. Vandenberg, R. A. Sayeed, and A. E. O. Trezise Cardiac Expression of the Cystic Fibrosis Transmembrane Conductance Regulator Involves Novel Exon 1 Usage to Produce a Unique Amino-terminal Protein J. Biol. Chem., April 16, 2004; 279(16): 15877 - 15887. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Baeza-Raja and P. Munoz-Canoves p38 MAPK-induced Nuclear Factor-{kappa}B Activity Is Required for Skeletal Muscle Differentiation: Role of Interleukin-6 Mol. Biol. Cell, April 1, 2004; 15(4): 2013 - 2026. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. D. I. Anderson, F. Wang, and D. G. Gardner Role of the Epidermal Growth Factor Receptor in Signaling Strain-dependent Activation of the Brain Natriuretic Peptide Gene J. Biol. Chem., March 5, 2004; 279(10): 9287 - 9297. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Pan, T. Kislinger, A. O. Gramolini, E. Zvaritch, E. G. Kranias, D. H. MacLennan, and A. Emili Identification of biochemical adaptations in hyper- or hypocontractile hearts from phospholamban mutant mice by expression proteomics PNAS, February 24, 2004; 101(8): 2241 - 2246. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. Babiker, L. J. De Windt, M. van Eickels, V. Thijssen, R. J.P. Bronsaer, C. Grohe, M. van Bilsen, and P. A. Doevendans 17{beta}-Estradiol Antagonizes Cardiomyocyte Hypertrophy by Autocrine/Paracrine Stimulation of a Guanylyl Cyclase A Receptor-Cyclic Guanosine Monophosphate-Dependent Protein Kinase Pathway Circulation, January 20, 2004; 109(2): 269 - 276. [Abstract] [Full Text] [PDF] |
||||
![]() |
S MUKADDAM-DAHER, A MENAOUAR, R EL-AYOUBI, J GUTKOWSKA, M JANKOWSKI, R. VELLIQUETTE, and P ERNSBERGER Cardiac Effects of Moxonidine in Spontaneously Hypertensive Obese Rats Ann. N.Y. Acad. Sci., December 1, 2003; 1009(1): 244 - 250. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mirotsou, C. M.H. Watanabe, P. G. Schultz, R. E. Pratt, and V. J. Dzau Elucidating the molecular mechanism of cardiac remodeling using a comparative genomic approach Physiol Genomics, October 17, 2003; 15(2): 115 - 126. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. M. MOORMAN and V. M. CHRISTOFFELS Cardiac Chamber Formation: Development, Genes, and Evolution Physiol Rev, October 1, 2003; 83(4): 1223 - 1267. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Weikert, M. Eppenberger-Eberhardt, and H. M Eppenberger Cellular engineering of ventricular adult rat cardiomyocytes Cardiovasc Res, October 1, 2003; 59(4): 874 - 882. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Liang, F. Wang, S. Zhang, and D. G. Gardner Peroxisome Proliferator Activated Receptor (PPAR){alpha} Agonists Inhibit Hypertrophy of Neonatal Rat Cardiac Myocytes Endocrinology, September 1, 2003; 144(9): 4187 - 4194. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ponten, X. Li, P. Thoren, K. Aase, T. Sjoblom, A. Ostman, and U. Eriksson Transgenic Overexpression of Platelet-Derived Growth Factor-C in the Mouse Heart Induces Cardiac Fibrosis, Hypertrophy, and Dilated Cardiomyopathy Am. J. Pathol., August 1, 2003; 163(2): 673 - 682. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Pikkarainen, H. Tokola, T. Majalahti-Palviainen, R. Kerkela, N. Hautala, S. S. Bhalla, F. Charron, M. Nemer, O. Vuolteenaho, and H. Ruskoaho GATA-4 Is a Nuclear Mediator of Mechanical Stretch-activated Hypertrophic Program J. Biol. Chem., June 20, 2003; 278(26): 23807 - 23816. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. W. Dorn II, J. Robbins, and P. H. Sugden Phenotyping Hypertrophy: Eschew Obfuscation Circ. Res., June 13, 2003; 92(11): 1171 - 1175. [Full Text] [PDF] |
||||
![]() |
J. C. Borges, J. A. Silva Jr., M. A. Gomes, E. S. L. Lomez, K. M. Leite, R. C. Araujo, M. Bader, J. B. Pesquero, and J. L. Pesquero Tonin in rat heart with experimental hypertrophy Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2263 - H2268. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Krenz, A. Sanbe, F. Bouyer-Dalloz, J. Gulick, R. Klevitsky, T. E. Hewett, H. E. Osinska, J. N. Lorenz, C. Brosseau, A. Federico, et al. Analysis of Myosin Heavy Chain Functionality in the Heart J. Biol. Chem., May 2, 2003; 278(19): 17466 - 17474. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Jalili, J. Manning, and S. Kim Increased Translocation of Cardiac Protein Kinase C {beta}2 Accompanies Mild Cardiac Hypertrophy in Rats Fed Saturated Fat J. Nutr., February 1, 2003; 133(2): 358 - 361. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yun, M. J Zuscik, P. Gonzalez-Cabrera, D. F McCune, S. A Ross, R. Gaivin, M. T Piascik, and D. M Perez Gene expression profiling of {alpha}1b-adrenergic receptor-induced cardiac hypertrophy by oligonucleotide arrays Cardiovasc Res, February 1, 2003; 57(2): 443 - 455. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Pikkarainen, H. Tokola, R. Kerkela, T. Majalahti-Palviainen, O. Vuolteenaho, and H. Ruskoaho Endothelin-1-specific Activation of B-type Natriuretic Peptide Gene via p38 Mitogen-activated Protein Kinase and Nuclear ETS Factors J. Biol. Chem., January 31, 2003; 278(6): 3969 - 3975. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Mihaljevic, S. Paul, L. H. Cohn, and A. Wechsler Pathophysiology of Aortic Valve Disease Card. Surg. Adult, January 1, 2003; 2(2003): 791 - 810. [Full Text] |
||||
![]() |
J. N. Tsoporis, A. Marks, L. J. Van Eldik, D. O'Hanlon, and T. G. Parker Regulation of the S100B gene by alpha 1-adrenergic stimulation in cardiac myocytes Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H193 - H203. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gupta, N. H. Purcell, A. Lin, and S. Sen Activation of nuclear factor-{kappa}B is necessary for myotrophin-induced cardiac hypertrophy J. Cell Biol., December 23, 2002; 159(6): 1019 - 1028. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Hahn, M. G. Yussman, T. Toyokawa, Y. Marreez, T. J. Barrett, K. C. Hilty, H. Osinska, J. Robbins, and G. W. Dorn II Ischemic Protection and Myofibrillar Cardiomyopathy: Dose-Dependent Effects of In Vivo {delta}PKC Inhibition Circ. Res., October 18, 2002; 91(8): 741 - 748. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Delhaas, S. van Engeland, J. Broers, C. Bouten, N. Kuijpers, F. Ramaekers, and L. H. E. H. Snoeckx Quantification of cytoskeletal deformation in living cells based on hierarchical feature vector matching Am J Physiol Cell Physiol, August 1, 2002; 283(2): C639 - C645. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-C. Battista, L. L. Oligny, J. St-Louis, and M. Brochu Intrauterine growth restriction in rats is associated with hypertension and renal dysfunction in adulthood Am J Physiol Endocrinol Metab, July 1, 2002; 283(1): E124 - E131. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. Post, C. Swiderski, B. A. Waldrop, L. Salty, C. C. Glembotski, R. M. F. Wolthuis, and N. Mochizuki Guanine Nucleotide Exchange Factor-like Factor (Rlf) Induces Gene Expression and Potentiates alpha 1-Adrenergic Receptor-induced Transcriptional Responses in Neonatal Rat Ventricular Myocytes J. Biol. Chem., May 3, 2002; 277(18): 15286 - 15292. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kerkela, S. Pikkarainen, T. Majalahti-Palviainen, H. Tokola, and H. Ruskoaho Distinct Roles of Mitogen-activated Protein Kinase Pathways in GATA-4 Transcription Factor-mediated Regulation of B-type Natriuretic Peptide Gene J. Biol. Chem., April 12, 2002; 277(16): 13752 - 13760. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yanazume, K. Hasegawa, H. Wada, T. Morimoto, M. Abe, T. Kawamura, and S. Sasayama Rho/ROCK Pathway Contributes to the Activation of Extracellular Signal-regulated Kinase/GATA-4 during Myocardial Cell Hypertrophy J. Biol. Chem., March 1, 2002; 277(10): 8618 - 8625. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Laufs, H. Kilter, C. Konkol, S. Wassmann, M. Bohm, and G. Nickenig Impact of HMG CoA reductase inhibition on small GTPases in the heart Cardiovasc Res, March 1, 2002; 53(4): 911 - 920. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Peterson Pressure overload hypertrophy and congestive heart failure: Where is the "Achilles' heel"? J. Am. Coll. Cardiol., February 20, 2002; 39(4): 672 - 675. [Full Text] [PDF] |
||||
![]() |
S. W. Bahouth, M. J. Beauchamp, and K. N. Vu Reciprocal Regulation of beta 1-Adrenergic Receptor Gene Transcription by Sp1 and Early Growth Response Gene 1: Induction of EGR-1 Inhibits the Expression of the beta 1-Adrenergic Receptor Gene Mol. Pharmacol., February 1, 2002; 61(2): 379 - 390. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Hakuno, K. Fukuda, S. Makino, F. Konishi, Y. Tomita, T. Manabe, Y. Suzuki, A. Umezawa, and S. Ogawa Bone Marrow-Derived Regenerated Cardiomyocytes (CMG Cells) Express Functional Adrenergic and Muscarinic Receptors Circulation, January 22, 2002; 105(3): 380 - 386. [Abstract] [Full Text] [PDF] |
||||